The apelinergic system: Sexual dimorphism and tissue-specificmodulations by obesity and insulin resistance in female mice

Peptides

Volumn 46, Issue , 2013, Pages 94-101

  Butruille, Laura ^a   Drougard, Anne ^b   Knauf, Claude ^b   Moitrot, Emmanuelle ^a   Valet, Philippe ^b   Storme, Laurent ^a   Deruelle, Philippe ^a   Lesage, Jean ^a  

^a UNIVERSITÉ DE LILLE   (France)

^b Université de Toulouse   (France)

Author keywords

Apelin APJ; Diabetes; Mouse; Obesity; Sexual dimorphism

Indexed keywords

APELIN; APELIN RECEPTOR; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APELINEMIA; ARTICLE; BLOOD SAMPLING; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIET RESTRICTION; ESTRUS CYCLE; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; WHITE ADIPOSE TISSUE;

MUS;

APELIN/APJ; DIABETES; MOUSE; OBESITY; SEXUAL DIMORPHISM;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; CIRCADIAN RHYTHM; DIET, HIGH-FAT; ESTROUS CYCLE; FASTING; FEMALE; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SEX FACTORS;

EID: 84879476021     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.05.013     Document Type: Article

References (47)

1. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, et al. Theendogenous peptide apelin potently improves cardiac contractility and reducescardiac loading in vivo. Cardiovasc Res 2005;65:73-82.
2. Attané C, Daviaud D, Dray C, Dusaulcy R, Masseboeuf M, Prévot D, et al. Apelinstimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. JMol Endocrinol 2011;46:21-8.
3. Bai B, Tang J, Liu H, Chen J, Li Y, Song W. Apelin-13 induces ERK1/2 but notp38 MAPK activation through coupling of the human apelin receptor to the Gi2pathway. Acta Biochim Biophys Sin (Shanghai) 2008;40:311-8.
4. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, et al. Apelin, anewly identified adipokine up-regulated by insulin and obesity. Endocrinology2005;146:1764-71.
5. Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C, Valet P. Apelin, diabetes,and obesity. Endocrine 2011;40:1-9.
6. Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Apelin, a promising tar-get for type 2 diabetes treatment? Trends Endocrinol Metab 2012;23:234-41.
7. Castan-Laurell I, Vítkova M, Daviaud D, Dray C, Kováciková M, Kovacova Z,et al. Effect of hypocaloric diet-induced weight loss in obese women onplasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol2008;158:905-10.
8. Chen S, Xue F, Jin HL, Chen L, Chen Y, Wang GF, et al. Effect of swimming exerciseon the expression of apelin and its receptor in pulmonary tissues of rats withhypoxic pulmonary hypertension. Zhongguo Ying Yong Sheng Li Xue Za Zhi2012;28:5-8.
9. Chen W, Oue T, Ueno T, Uehara S, Usui N, Fukuzawa M. Apelin is a marker ofthe progression of liver fibrosis and portal hypertension in patients with biliaryatresia. Pediatr Surg Int 2013;29:79-85.
10. Clarke KJ, Whitaker KW, Reyes TM. Diminished metabolic responses tocentrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet.J Neuroendocrinol 2009;21:83-9.
11. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligandfor the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic fac-tor required for normal vascular development of the frog embryo. Dev Biol2006;296:177-89.
12. Day RT, Cavaglieri RC, Feliers D. Apelin retards the progression ofdiabetic nephropathy. Am J Physiol Renal Physiol 2013;304:F788-800,http://dx. doi.org/10.1152/ajprenal.00306.2012.
13. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, et al. Apelin stimu-lates glucose utilization in normal and obese insulin-resistant mice. Cell Metab2008;8:437-45.
14. Duparc T, Colom A, Cani PD, Massaly N, Rastrelli S, Drougard A, et al. Centralapelin controls glucose homeostasis via a nitric oxide-dependent pathway inmice. Antioxid Redox Signal 2011;15:1477-96.
15. Falcão-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenç o AP, Leite-MoreiraAF. Physiological, pathological and potential therapeutic roles of adipokines.Drug Discov Today 2012;17:880-9.
16. Fan XF, Wang Q, Mao SZ, Hu LG, Hong L, Tian LX, et al. Protective and therapeuticeffect of apelin on chronic hypoxic pulmonary hypertension in rats. ZhongguoYing Yong Sheng Li Xue Za Zhi 2010;26:9-12.
17. Heinonen MV, Purhonen AK, Miettinen P, Pääkkönen M, Pirinen E, Alhava E,et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect ofgastric banding. Regul Pept 2005;130:7-13.
18. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, et al. Apelin,an APJ receptor ligand, regulates body adiposity and favors the messengerribonucleic acid expression of uncoupling proteins in mice. Endocrinology2007;148:2690-7.
19. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, et al. Molec-ular and functional characteristics of APJ: tissue distribution of mRNA andinteraction with the endogenous ligand apelin. J Biol Chem 2000;275:21061-7.
20. Hus-Citharel A, Bouby N, Frugiere A, Bodineau L, Gasc JM, Llorens-Cortes C.Effect of apelin on glomerular hemodynamic function in the rat kidney. KidneyInt 2008;74:486-94.
21. Ivars J, Butruille L, Knauf C, Bouckenooghe T, Mayeur S, Vieau D, et al. Maternalhypertension induces tissue-specific modulations of the apelinergic system inthe fetoplacental unit in rat. Peptides 2012;35:136-8.
22. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, et al.Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008;52:908-13.
23. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, et al. Molecularproperties of apelin: tissue distribution and receptor binding. Biochim BiophysActa 2001;1538:162-71.
24. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine.Pharmacol Ther 2005;107:198-211.
25. Lee DK, George SR, O'Dowd BF. Unravelling the roles of the apelin sys-tem: prospective therapeutic applications in heart failure and obesity. TrendsPharmacol Sci 2006;27:190-4.
26. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, et al. Changes and relations ofcirculating visfatin, apelin, and resistin levels in normal, impaired glucose tol-erance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006;114:544-8.
27. Liu C, Su T, Li F, Li L, Qin X, Pan W, et al. PI3K/Akt signaling transduc-tion pathway is involved in rat vascular smooth muscle cell proliferationinduced by apelin-13. Acta Biochim Biophys Sin (Shanghai) 2010;42:396-402.
28. Llorens-Cortes C, Moos F. Apelin and vasopressin: two work better than one. JNeuroendocrinol 2012;24:1085-6.
29. Masaki T, Yasuda T, Yoshimatsu H. Apelin-13 microinjection into the para-ventricular nucleus increased sympathetic nerve activity innervating brownadipose tissue in rats. Brain Res Bull 2012;87:540-3.
30. Melgar-Lesmes P, Pauta M, Reichenbach V, Casals G, Ros J, BatallerR, et al. Hypoxia and proinflammatory factors upregulate apelin recep-tor expression in human stellate cells and hepatocytes. Gut 2011;60:1404-11.
31. O'Shea M, Hansen MJ, Tatemoto K, Morris MJ. Inhibitory effect of apelin-12 onnocturnal food intake in the rat. Nutr Neurosci 2003;6:163-7.
32. Poirier O, Ciumas M, Eyries M, Montagne K, Nadaud S, Soubrier F. Inhibitionof apelin expression by bmp signaling in endothelial cells. Am J Physiol CellPhysiol 2012;303:C1139-45, http://dx.doi.org/10.1152/ajpcell.00168. 2012.
33. Pope GR, Roberts EM, Lolait SJ, O'Carroll AM. Central and peripheral apelinreceptor distribution in the mouse: species differences with rat. Peptides2012;33:139-48.
34. Reaux-Le Goazigo A, Alvear-Perez R, Zizzari P, Epelbaum J, Bluet-Pajot MT,Llorens-Cortes C. Cellular localization of apelin and its receptor in the anteriorpituitary: evidence for a direct stimulatory action of apelin on ACTH release.Am J Physiol Endocrinol Metab 2007;292:7-15.
35. Reaux-Le Goazigo A, Bodineau L, De Mota N, Jeandel L, Chartrel N, KnaufC, et al. Apelin and the proopiomelanocortin system: a new regulatorypathway of hypothalamic -MSH release. Am J Physiol Endocrinol Metab2011;301:955-66.
36. Schilffarth S, Antoni B, Schams D, Meyer HH, Berisha B. The expression of apelinand its receptor APJ during different physiological stages in the bovine ovary.Int J Biol Sci 2009;5:344-50.
37. Shimizu T, Kosaka N, Murayama C, Tetsuka M, Miyamoto A. Apelin and APJreceptor expression in granulosa and theca cells during different stages of follic-ular development in the bovine ovary: Involvement of apoptosis and hormonalregulation. Anim Reprod Sci 2009;116:28-37.
38. Siddiquee K, Hampton J, McAnally D, May LT, Smith LH. Theapelin receptor inhibits the angiotensin II type 1 receptor viaallosteric trans-inhibition. Br J Pharmacol 2013;168:1104-17,http://dx.doi.org/10.1111/j.1476-5381.2012.02192.
39. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM,Garcia-Arnes J, Tinahones FJ, et al. Apelin levels are increased in mor-bidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009;19:1574-80.
40. Sunter D, Hewson AK, Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003;353:1-4.
41. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, et al. Thenovel peptide apelin lowers blood pressure via a nitric oxide-dependent mech-anism. Regul Pept 2001;99:87-92.
42. Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ, et al. Apelin inhibits adipo-genesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol2012;36:227-41.
43. Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central admin-istration of apelin-13 over 10 days increases food intake, body weight,locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol2008;20:79-84.
44. Visser YP, Walther FJ, Laghmani el H, Laarse A, Wagenaar GT. Apelin attenuateshyperoxic lung and heart injury in neonatal rats. Am J Respir Crit Care Med2010;182:1239-50.
45. Xu S, Han P, Huang M, Wu JC, Chang C, Tsao PS, et al. In vivo, ex vivo, andin vitro studies on apelin's effect on myocardial glucose uptake. Peptides2012;37:320-6.
46. Yokomori H, Oda M, Yoshimura K, Hibi T. Enhanced expressions of apelin onproliferative hepatic arterial capillaries in human cirrhotic liver. Hepatol Res2012;42:508-14.
47. Yue P, Jin H, Xu S, Aillaud M, Deng AC, Azuma J, et al. Apelin decreaseslipolysis via G(q), G(i), and AMPK-dependent mechanisms. Endocrinology2011;152:59-68.